Oxygen

Oxygen

SCHEMBL4285246

Cl.O=O

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Oxygen. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Oxygen SCHEMBL30427251 0.87
Oxygen SCHEMBL28497021 0.82
Oxygen SCHEMBL821 0.82
Oxygen SCHEMBL7862762 0.67
Oxygen SCHEMBL15808690 0.67
Oxygen SCHEMBL25433023 0.67
Oxygen SCHEMBL10414366 0.67
Oxygen SCHEMBL587724 0.67
Oxygen SCHEMBL5480163 0.67
Oxygen SCHEMBL11586663 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116272311-A ClO utilization method 2 Method for treating industrial waste gas 山东大学 2023-06-23 CN claimed
US-11655167-B2 Methods for eradicating biofilms from plumbing systems GORDON & ROSENBLATT, LLC (US) 2023-05-23 US claimed
EP-1797947-B1 Encapsulated active material with reduced formaldehyde potential INT FLAVORS & FRAGRANCES INC (US) 2013-03-27 EP claimed
US-20090258042-A1 Encapsulated Active Materials Containing Adjunct Crosslinkers INTERNATIONAL FLAVORS & FRAGRANCES INC. 2009-10-15 US claimed
US-20070138671-A1 Encapsulated active material with reduced formaldehyde potential INTERNATIONAL FLAVORS & FRAGRANCES INC. 2007-06-21 US claimed
US-20070138674-A1 ENCAPSULATED ACTIVE MATERIAL WITH REDUCED FORMALDEHYDE POTENTIAL INTERNATIONAL FLAVORS & FRAGRANCES INC. 2007-06-21 US claimed
EP-1797947-A2 Encapsulated active material with reduced formaldehyde potential INTERNATIONAL FLAVORS &amp; FRAGRANCES, INC. (US) 2007-06-20 EP claimed
US-12600960-B2 Xylanase variants AB ENZYMES FINLAND OY (FI) 2026-04-14 US disclosed
US-20250019682-A1 Xylanase Variants AB ENZYMES GMBH (DE) 2025-01-16 US disclosed
CN-221956909-U Portable winch type quick inflation siphon drainage device 中交广州水运工程设计研究院有限公司 2024-11-05 CN disclosed
CN-117062909-A Xylanase variants 生化酶股份有限公司 2023-11-14 CN disclosed
EP-4267731-A1 XYLANASE VARIANTS AB Enzymes Oy (FI) 2023-11-01 EP disclosed
WO-2022144500-A1 XYLANASE VARIANTS AB ENZYMES OY (FI) 2022-07-07 WO disclosed
EP-4019629-A1 XYLANASE VARIANTS AB Enzymes Oy (FI) 2022-06-29 EP disclosed
EP-1797947-B1 Encapsulated active material with reduced formaldehyde potential INT FLAVORS & FRAGRANCES INC (US) 2013-03-27 EP disclosed
EP-2545988-A2 Encapsulated active material with reduced formaldehyde potential International Flavors & Fragrances, Inc. (US) 2013-01-16 EP disclosed
US-20090258042-A1 Encapsulated Active Materials Containing Adjunct Crosslinkers INTERNATIONAL FLAVORS & FRAGRANCES INC. 2009-10-15 US disclosed
US-20070138671-A1 Encapsulated active material with reduced formaldehyde potential INTERNATIONAL FLAVORS & FRAGRANCES INC. 2007-06-21 US disclosed
US-20070138674-A1 ENCAPSULATED ACTIVE MATERIAL WITH REDUCED FORMALDEHYDE POTENTIAL INTERNATIONAL FLAVORS & FRAGRANCES INC. 2007-06-21 US disclosed
EP-1797947-A2 Encapsulated active material with reduced formaldehyde potential INTERNATIONAL FLAVORS &amp; FRAGRANCES, INC. (US) 2007-06-20 EP disclosed